3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
37
Recruiting
9
Withdrawn
7
Terminated
7
Unknown
5
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
32
Neoplasms
28
Colorectal Neoplasms
19
Prostatic Neoplasms
16
Lung Neoplasms
13
Leukemia, Myeloid, Acute
12
Glioblastoma
12
Stomach Neoplasms
10
Head and Neck Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pancreatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Melanoma
8
Glioma
8
Brain Neoplasms
8
Rectal Neoplasms
7
Carcinoma, Hepatocellular
7
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Hematologic Neoplasms
6
Uterine Cervical Neoplasms
5
Polycystic Ovary Syndrome
5
Myelodysplastic Syndromes
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Carcinoma, Renal Cell
5
Triple Negative Breast Neoplasms
4
Lymphoma, B-Cell
4
Lymphoma
4
Depression
4
Interventions
pimonidazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
OTHER
×
Tongue Neoplasms
×
Clear all
NCT03181035
2024-08-12
FAITH
Sunnybrook Health Sciences Centre
Phase 1/2
Suspended
10 enrolled